PHCRF (Healius) Sale Of Investment : $0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Healius Sale Of Investment?

Healius's sale of investment for the six months ended in Jun. 2024 was $0 Mil. It means Healius gained $0 Mil from selling investments. Healius's sale of investment for the trailing twelve months (TTM) ended in Jun. 2024 was $0 Mil.

Compared with last quarter ($0 Mil in Dec. 2023 ), Healius gained the same money from selling investments in Jun. 2024 ($0 Mil).

Healius Sale Of Investment Historical Data

The historical data trend for Healius's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healius Sale Of Investment Chart

Healius Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Sale Of Investment

Get a 7-Day Free Trial

Healius Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Sale Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Healius Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

Healius Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Healius's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Healius Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Healius Ltd (OTCPK:PHCRF) » Definitions » Sale Of Investment

Comparable Companies

Traded in Other Exchanges

PGZ:Germany HLS:Australia

Address

161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000

Website

https://www.healius.com.au

Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider, though the latter business is set to be sold in early 2025. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.